Fiduciary Trust International of Pennsylvania’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,778	Closed	-$63K	–	378
2019 Q4	$63K	Hold	2,778	–	–	﹤0.01%	321
2019 Q3	$40K	Hold	2,778	–	–	﹤0.01%	373
2019 Q2	$37K	Hold	2,778	–	–	﹤0.01%	368
2019 Q1	$48K	Buy	+2,778	New	+$41.4K	﹤0.01%	319
2018 Q4	–	Sell	-12,524	Closed	-$269K	–	341
2018 Q3	$269K	Buy	12,524 +3,302	+36%	+$100K	0.01%	318
2018 Q2	$395K	Buy	+9,222	New	+$422K	0.02%	283

Other funds holding LUMO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's LUMO Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 2,778 shares — an estimated $63K sold.

Fiduciary Trust International of Pennsylvania first reported a position in LUMO in Q2 2018 and held it in 6 quarters. The position peaked at $395K in Q2 2018. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

Fiduciary Trust International of Pennsylvania reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Fiduciary Trust International of Pennsylvania sold 2,778 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $63K.
Fiduciary Trust International of Pennsylvania first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
Fiduciary Trust International of Pennsylvania's Lumos Pharma, Inc. Common Stock position peaked at $395K in Q2 2018.
46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.